OpenAlex
PricingAboutJobs
Log inGet started
Work

Glucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same?

HTML

Year: 2018
Type: review
Source: Diabetes/Metabolism Research and Reviews
DOI: 10.1002/dmrr.3070
Authors: Raffaella Gentilella, Valeria Pechtner, Antonella Corcos, Agostino Consoli
Institutions: Eli Lilly (Italy), University of Chieti-Pescara
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, type 2 diabetes, exenatide, lixisenatide, albiglutide, dulaglutide, liraglutide, semaglutide, exendin-4, gastric emptying, glucose-dependent insulin secretion, glucagon secretion, weight loss, immunogenicity, gastrointestinal tolerance, medication adherence, drug administration routes
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W2889521172
FWCI: 3.585
Cites: 131
Cited by: 259
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security